Myth, menace or medical blessing? The clinical potential and problems of genetic vaccines

Expert Opinion on Biological Therapy

Volumn 3, Issue 1, 2003, Pages 1-4

  Leitner, Wolfgang W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; PLASMID DNA;

CPG ISLAND; CYTOTOXIC T LYMPHOCYTE; DNA SEQUENCE; DNA VECTOR; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; SIDE EFFECT; VACCINATION;

ANIMALS; CLINICAL TRIALS; GENETIC VECTORS; HUMANS; VACCINES, DNA;

EID: 0037319218     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.3.1.1     Document Type: Editorial

References (23)

1. REYES-SANDOVAL A, ERTL HC: DNA vaccines. Curr. Mol. Med. (2001) 1:217-243.
2. LEITNER WW, HAMMERL P, THALHAMER J: Nucleic acid for the treatment of cancer: genetic vaccines and DNA adjuvants. Curr. Pharm. Des. (2001) 7:1641-1667.
3. PERRIN P, JACOB Y, DESMEZIERES E et al.: DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines. Dev. Biol. (Basel) (2000) 104:151-157.
4. LORENZEN N, LORENZEN E, EINERJENSEN K et al.: Immunity induced shortly after DNA vaccination of rainbow trout against rhabdoviruses protects against heterologous virus but not against bacterial pathogens. Dev. Comp. Immunol. (2002) 26:173-179.
5. CORBEIL S, LAPATRA SE, ANDERSON ED et al.: Nanogram quantities of a DNA vaccine protect rainbow trout fry against heterologous strains of infectious hematopoietic necrosis virus. Vaccine (2000) 18:2817-2824.
6. LAPATRA SE, CORBEIL S, JONES GR et al.: Protection of rainbow trout against infectious hematopoietic necrosis virus four days after specific or semi-specific DNA vaccination. Vaccine (2001) 19:4011-4019.
7. NUSBAUM KE, SMITH BF, DEINNOCENTES P et al.: Protective immunity induced by DNA vaccination of channel catfish with early and late transcripts of the channel catfish herpesvirus (IHV-1). Vet. Immunol. Immunopathol. (2002) 84:151-168.
8. HEPPELL J, DAVIS HL: Application of DNA vaccine technology to aquaculture. Adv. Drug Deliv. Rev. (2000) 43:29-43.
9. FERNANDEZ-ALONSO M, ROCHA A, COLL JM: DNA vaccination by immersion and ultrasound to trout viral haemorrhagic septicaemia virus. Vaccine (2001) 19:3067-3075.
10. KRIEG AM, YI AK, MATSON S et al.: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 374:546-549.
11. ASHKAR AA, ROSENTHAL KL: Toll-like receptor 9, CpG DNA and innate immunity. Curr. Mol. Med. (2002) 2:545-556.
12. KRIEG AM, WAGNER H: Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA. Immunol. Today (2000) 21:521-526.
13. DAVIS HL: CpG motifs for optimization of DNA vaccines. Dev. Biol. (Basel) (2000) 104:165-169.
14. BERGLUND P, TUBULEKAS I, LILJESTROM P: Alphaviruses as vectors for gene delivery. Trends. Biotechnol. (1996) 14:130-134.
15. LEITNER WW, YING H, DRIVER DA et al.: Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Res. (2000) 60:51-55.
16. YING H, ZAKS TZ, WANG RF et al.: Cancer therapy using a self-replicating RNA vaccine. Nat. Med. (1999) 5:823-827.
17. LEITNER WW, HWANG LH, DEVEER MJ et al.: Alphavirus-based DNA vaccine breaks immuological tolerance by activating in nate antiviral pathways. Nat. Med (2003) 9(1):33-39.
18. FYNAN EF, WEBSTER RG, FULLER DH et al.: DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Nalt. Acad. Sci. USA (1993) 90:11478-11482.
19. YOSHIDA A, NAGATA T, UCHIJIMA M et al.: Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses. Vaccine (2000) 18:1725-1729.
20. ROY MJ, WU MS, BARR LJ et al.: Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine (2000) 19:764-768.
21. PORGADOR A, IRVINE KR, IWASAKI A et al.: Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J. Exp. Med. (1998) 188:1075-1082.
22. IRVINE KR, CHAMBERLAIN RS, SHULMAN EP et al.: Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors. J. Nat. Cancer Inst. (1997) 89:1595-1601.
23. HILL AV, REECE W, GOTHARD P et al.: DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy. Dev. Biol. (Basel) (2000) 104:171-179.